ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

IMNM Immunome Inc

16.00
0.25 (1.59%)
取引時間後
最終更新日: 07:19:48
15分遅延
名称 銘柄コード 市場 種別
Immunome Inc IMNM NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.25 1.59% 16.00 07:19:48
始値 安値 高値 終値 前日終値
15.75 15.12 16.1799 15.46 15.75
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0221:00BWImmunome Appoints Kinney Horn as Chief Business Officer
2024/4/2521:26BWImmunome Appoints Sandra M. Swain to Board of Directors
2024/4/0521:00BWImmunome to Present Preclinical Data for IM-3050, Its Lead..
2024/3/2905:02BWImmunome Reports Full Year 2023 Financial Results and..
2024/3/2621:00BWImmunome Completes Acquisition of AL102, a Phase 3 Asset for..
2024/3/0722:00BWImmunome to Participate in the Leerink Partners Global..
2024/3/0122:00BWImmunome to Participate in the TD Cowen 44th Annual..
2024/2/2211:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2211:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/2022:15BWImmunome Recognizes Ayala Pharmaceuticals’ Announced..
2024/2/1706:05BWImmunome Announces Closing of Public Offering and Full..
2024/2/1506:11EDGAR2Form 8-K - Current report
2024/2/1506:09EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1412:38BWImmunome Announces Pricing of Public Offering of Common..
2024/2/1406:36EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/2/1406:10EDGAR2Form 8-K - Current report
2024/2/1406:05BWImmunome Announces Proposed Public Offering of Common Stock
2024/2/1304:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0622:05EDGAR2Form 8-K - Current report
2024/2/0522:00BWImmunome to Present at the Guggenheim Healthcare Talks 6th..
2024/2/0306:04EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/2/0110:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0110:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1207:27EDGAR2Form 8-K - Current report
2024/1/0821:05EDGAR2Form 8-K - Current report
2024/1/0821:00BWImmunome Exclusively Licenses Zentalis ROR1 Antibody-Drug..
2024/1/0507:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/0422:00BWImmunome Appoints Phil Roberts as Chief Technical Officer
2024/1/0322:00BWImmunome to Present at the 42nd Annual J.P. Morgan..
2024/1/0222:05EDGAR2Form 8-K - Current report
2024/1/0222:00BWImmunome Appoints Carol A. Schafer to Board of Directors
2023/12/3007:00EDGAR2Form 8-K - Current report
2023/12/2622:35EDGAR2Form 8-K - Current report
2023/12/2622:30GLOBEAtreca Announces Asset Purchase Agreement for Sale of..
2023/12/1609:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/0611:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2814:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/2306:02EDGAR2Form 8-K/A - Current report: [Amend]
2023/11/1706:08EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/1520:03EDGAR2Form 8-K - Current report
2023/11/1022:00BWImmunome to Present at the Stifel 2023 Healthcare Conference
2023/11/1006:52EDGAR2Form 8-K - Current report
2023/11/0922:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0922:00BWImmunome Reports Third Quarter 2023 Financial Results
2023/11/0822:30EDGAR2Form 8-K - Current report
2023/11/0822:00BWImmunome Appoints Jean-Jacques Bienaimé to Board of..
2023/11/0107:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0107:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0107:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/1921:00BWImmunome Appoints Bob Lechleider, M.D., as Chief Medical..

最近閲覧した銘柄

Delayed Upgrade Clock